Potential mechanisms of antitumorigenesis by protease inhibitors
- PMID: 8304942
- DOI: 10.1007/978-1-4615-2984-2_28
Potential mechanisms of antitumorigenesis by protease inhibitors
Abstract
The mechanisms by which protease inhibitors suppress carcinogenesis are unknown. From our studies, we believe the first event in carcinogenesis is a high frequency epigenetic event and that a later event (presumably genetic) leads to the malignant state. Protease inhibitors appear to be capable of reversing the "initiating" event in carcinogenesis, even at long times after carcinogen exposure. Protease inhibitors are thought to stop an ongoing process begun by carcinogen exposure. Effects of protease inhibitors on the following phenomena are thought to be related to their anticarcinogenic activity: 1) ability to effect the expression of certain oncogenes, and 2) ability to return carcinogen-increased levels of certain proteolytic activities (e.g., Boc-val-pro-arg-MCA hydrolyzing activity) to normal levels. Other effects of anticarcinogenic protease inhibitors have also been observed; for example, we have reported that they can bring carcinogen-induced, elevated levels of gene amplification to nearly normal levels. The mechanism(s) by which protease inhibitors suppress carcinogenesis will not be determined with certainty until the mechanisms involved in cancer induction are known.
Similar articles
-
Prevention of carcinogenesis by protease inhibitors.Cancer Res. 1994 Apr 1;54(7 Suppl):1999s-2005s. Cancer Res. 1994. PMID: 8137328 Review.
-
Effects of protease inhibitors on levels of proteolytic activity in normal and premalignant cells and tissues.J Cell Biochem Suppl. 1995;22:188-94. doi: 10.1002/jcb.240590824. J Cell Biochem Suppl. 1995. PMID: 8538198 Review.
-
A serine protease activity in C3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors.Proc Natl Acad Sci U S A. 1987 Jul;84(14):4801-5. doi: 10.1073/pnas.84.14.4801. Proc Natl Acad Sci U S A. 1987. PMID: 3299374 Free PMC article.
-
Is there a critical target gene for the first step in carcinogenesis?Environ Health Perspect. 1991 Jun;93:199-203. doi: 10.1289/ehp.9193199. Environ Health Perspect. 1991. PMID: 1773792 Free PMC article. Review.
-
Intestinal epithelial cells contain a high molecular weight protease subject to inhibition by anticarcinogenic protease inhibitors.Cancer Lett. 1992 Apr 15;63(2):135-42. doi: 10.1016/0304-3835(92)90063-2. Cancer Lett. 1992. PMID: 1562990
Cited by
-
Two crystal structures of the leupeptin-trypsin complex.Protein Sci. 1996 Apr;5(4):752-8. doi: 10.1002/pro.5560050420. Protein Sci. 1996. PMID: 8845765 Free PMC article.
-
Recent Advances in Electrochemical Biosensors Based on Enzyme Inhibition for Clinical and Pharmaceutical Applications.Sensors (Basel). 2018 Jan 9;18(1):164. doi: 10.3390/s18010164. Sensors (Basel). 2018. PMID: 29315246 Free PMC article. Review.